Esperion Hopes CVOT Will Help Drive Nexletol/Nexlizet’s Market Uptake

 
• By Alaric DeArment
  
Esperion announced topline results from the CLEAR Outcomes trial • Source: Shutterstock

More from Clinical Trials

More from R&D